Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 29,500 OLMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 29,500 | n/a |
| Jun 13, 2025 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 24,150 | n/a |
| Jun 18, 2024 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 23,000 | n/a |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 59,399 | n/a |
| Jun 21, 2023 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 21,520 | n/a |
| Mar 31, 2023 | LianBio (LIAN) | Grant/Award | 325,901 | n/a |
| Jan 24, 2023 | LianBio (LIAN) | Grant/Award | 464,099 | n/a |
| Jun 17, 2022 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 21,520 | n/a |
| Dec 3, 2021 | LianBio (LIAN) | Grant/Award | 5,996 | n/a |
| Nov 1, 2021 | LianBio (LIAN) | Grant/Award | 229,538 | n/a |